{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:18Z","timestamp":1772165718226,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Scientific Research Foundation of Zhejiang Province","award":["2018KY809"],"award-info":[{"award-number":["2018KY809"]}]},{"name":"Technology Bureau Program of Jiaxing, Zhejiang Province","award":["2020AD300035"],"award-info":[{"award-number":["2020AD300035"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-invasive prenatal screening (NIPS) is widely used as the alternative choice for pregnant women at high-risk of fetal aneuploidy. However, whether NIPS has a good detective efficiency for pregnant women at advanced maternal age (AMA) has not been fully studied especially in Chinese women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twenty-nine thousand three hundred forty-three pregnant women at AMA with singleton pregnancy who received NIPS and followed-up were recruited. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), receiver operating characteristic (ROC) curves and the Youden Index for detecting fetal chromosomal aneuploidies were analyzed. The relationship between maternal age and common fetal chromosomal aneuploidy was observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The sensitivity, specificity, PPV, NPV of NIPS for detecting fetal trisomy 21 were 99.11, 99.96, 90.98, and 100%, respectively. These same parameters for detecting fetal trisomy 18 were 100, 99.94, 67.92, and 100%, respectively. Finally, these parameters for detecting trisomy 13 were 100, 99.96, 27.78, and 100%, respectively. The prevalence of fetal trisomy 21 increased exponentially with maternal age. The high-risk percentage incidence rate of fetal trisomy 21 was significantly higher in the pregnant women at 37\u2009years old or above than that in pregnant women at 35 to 37\u2009years old. (\n                      <jats:italic>Youden index<\/jats:italic>\n                      \u2009=\u200937).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>It is indicated that NIPS is an effective prenatal screening method for pregnant women at AMA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-021-03570-6","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T07:18:32Z","timestamp":1611645512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficiency of non-invasive prenatal screening in pregnant women at advanced maternal age"],"prefix":"10.1186","volume":"21","author":[{"given":"Hui","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinglei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeqing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4344-7924","authenticated-orcid":false,"given":"Minyue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,26]]},"reference":[{"issue":"1","key":"3570_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4103\/0366-6999.221268","volume":"131","author":"HX Zhang","year":"2018","unstructured":"Zhang HX, Zhao YY, Wang YQ. Analysis of the characteristics of pregnancy and delivery before and after implementation of the two-child policy. Chin Med J. 2018;131(1):37\u201342.","journal-title":"Chin Med J"},{"issue":"6","key":"3570_CR2","first-page":"423","volume":"39","author":"TF Chen","year":"2016","unstructured":"Chen TF, Mao QQ, Lu LP, Lu WB. Relationship between fetal karyotype and age of pregnancy. Chinese J Laboratory Med. 2016;39(6):423\u20136.","journal-title":"Chinese J Laboratory Med"},{"issue":"2","key":"3570_CR3","first-page":"173","volume":"12","author":"XJ Lin","year":"2016","unstructured":"Lin XJ, Sun QM, He XC, Wu J, Ge TT, Dai WS. Clinical analysis of fetal chromosomes karyotype abnormalities. Chin J Obstetrics Gynecol Pediatrics (Electronic Edition). 2016;12(2):173\u20138.","journal-title":"Chin J Obstetrics Gynecol Pediatrics (Electronic Edition)"},{"issue":"9","key":"3570_CR4","first-page":"709","volume":"36","author":"YP Chen","year":"2016","unstructured":"Chen YP, Zheng FX, Zhou Q, Zhang XQ, Zhang F, Huang RP, Miu TT, Yu B. Application of high-throughput sequencing in the diagnosis of fetal aneuploidies in women with advanced maternal age. Reproduction Contraception. 2016;36(9):709.","journal-title":"Reproduction Contraception"},{"key":"3570_CR5","volume-title":"Study on fetal chromosome abnormality and appropriate prenatal diagnostic technique","author":"YN Zhu","year":"2015","unstructured":"Zhu YN. Study on fetal chromosome abnormality and appropriate prenatal diagnostic technique. Zhengjiang: Zhejiang University; 2015."},{"issue":"2","key":"3570_CR6","first-page":"215","volume":"70","author":"J Beta","year":"2018","unstructured":"Beta J, Lesmes-Heredia C, Bedetti C, Akolekar R. Risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review of the literature. Minerva Ginecol. 2018;70(2):215\u20139.","journal-title":"Minerva Ginecol"},{"issue":"1","key":"3570_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000089047","volume":"21","author":"Y Suzuki","year":"2006","unstructured":"Suzuki Y, Yamamoto T, Kojima K, Tanemura M, Tateyama H, Suzumori K. Evaluation levels of cytokines in amniotic fluid of women with intrauterine infection in the early second trimester. Fetal Diagn Ther. 2006;21(1):45\u201350.","journal-title":"Fetal Diagn Ther"},{"issue":"10","key":"3570_CR8","first-page":"1074","volume":"37","author":"F Chen","year":"2020","unstructured":"Chen F, Tan M, Xu Y, Zhu B, Li J, Lin K, Chen M, Zeng L. Retrospective analysis and mining of data from 10 840 patients undergoing non-invasive prenatal screening. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020;37(10):1074\u20138.","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"issue":"1","key":"3570_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/aogs.13047","volume":"96","author":"E Iwarsson","year":"2017","unstructured":"Iwarsson E, Jacobsson B, Dagerhamn J, Davidson T, Bernabe E, Heibert AM. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2017;96(1):7\u201318.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"3570_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/uog.12504","volume":"42","author":"MM Gil","year":"2013","unstructured":"Gil MM, Quezada MS, Bregant B, Ferraro M, Nicolaides KH. Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies. Ultrasound Obstet Gynecol. 2013;42(1):34\u201340.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"3570_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/1471-0528.14050","volume":"124","author":"FL Mackie","year":"2017","unstructured":"Mackie FL, Hemming K, Allen S, Morris RK, Kilby MD. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. Bjog. 2017;124(1):32\u201346.","journal-title":"Bjog."},{"key":"3570_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2016.05.004","volume":"76","author":"S Drury","year":"2016","unstructured":"Drury S, Hill M, Chitty LS. Cell-free fetal DNA testing for prenatal diagnosis. Adv Clin Chem. 2016;76:1\u201335.","journal-title":"Adv Clin Chem"},{"key":"3570_CR13","unstructured":"Expert Committee on Prenatal Screening and Diagnosis of Clinical Examination Center, National Health Commission. Expert consensus on laboratory technology on prenatal screening of fetal free DNA in maternal peripheral blood[J]. Chin J Lab Med. 2019;42(5):341\u201346."},{"key":"3570_CR14","first-page":"57","volume":"5","author":"F Jiang","year":"2012","unstructured":"Jiang F, Ren J, Chen F, Zhou Y, Xie J, Dan S, Su Y, Xie J, Yin B, Su W, Zhang H, Wang W, Chai X, Lin L, Guo H, Li Q, Li P, Yuan Y, Pan X, Li Y, Liu L, Chen H, Xuan Z, Chen S, Zhang C, Zhang H, Tian Z, Zhang Z, Jiang H, Zhao L, Zheng W, Li S, Li Y, Wang J, Wang J, Zhang X. Noninvasive fetal trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies. BMC Med Genet. 2012;5:57.","journal-title":"BMC Med Genet"},{"issue":"6","key":"3570_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/pd.4110","volume":"33","author":"S Chen","year":"2013","unstructured":"Chen S, Lau TK, Zhang C, Xu C, Xu Z, Hu P, Xu J, Huang H, Pan L, Jiang F, Chen F, Pan X, Xie W, Liu P, Li X, Zhang L, Li S, Li Y, Xu X, Wang W, Wang J, Jiang H, Zhang X. A method for noninvasive detection of fetal large deletions\/duplications by low coverage massively parallel sequencing. Prenat Diagn. 2013;33(6):584\u201390.","journal-title":"Prenat Diagn"},{"issue":"1","key":"3570_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/14767058.2017.1369947","volume":"32","author":"M Chen","year":"2019","unstructured":"Chen M, Fu XY, Luo YQ, Qian YQ, Pan L, Wang LY, Dong MY. Detection of fetal duplication 16p11.2q12.1 by next-generation sequencing of maternal plasma and invasive diagnosis. J Matern Fetal Neonatal Med. 2019;32(1):38\u201345.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"7","key":"3570_CR17","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/aje\/kwj063","volume":"163","author":"NJ Perkins","year":"2006","unstructured":"Perkins NJ, Schisterman EF. The inconsistency of \"optimal\" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163(7):670\u20135.","journal-title":"Am J Epidemiol"},{"issue":"10025","key":"3570_CR18","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/S0140-6736(16)30020-4","volume":"387","author":"W Gong","year":"2016","unstructured":"Gong W, Xu DR, Caine ED. Challenges arising from China's two-child policy. Lancet. 2016;387(10025):1274.","journal-title":"Lancet."},{"issue":"1","key":"3570_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000271995","volume":"27","author":"A Tabor","year":"2010","unstructured":"Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther. 2010;27(1):1\u20137.","journal-title":"Fetal Diagn Ther"},{"issue":"3","key":"3570_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/AOG.0b013e318162eb53","volume":"111","author":"AO Odibo","year":"2008","unstructured":"Odibo AO, Gray DL, Dicke JM, Stamilio DM, Macones GA, Crane JP. Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experience. Obstet Gynecol. 2008;111(3):589\u201395.","journal-title":"Obstet Gynecol"},{"issue":"9053","key":"3570_CR21","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0140-6736(96)08169-X","volume":"349","author":"LC Stranc","year":"1997","unstructured":"Stranc LC, Evans JA, Hamerton JL. Chorionic villus sampling and amniocentesis for prenatal diagnosis. Lancet. 1997;349(9053):711\u20134.","journal-title":"Lancet."},{"issue":"9076","key":"3570_CR22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","volume":"350","author":"YM Lo","year":"1997","unstructured":"Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485\u20137.","journal-title":"Lancet."},{"key":"3570_CR23","doi-asserted-by":"publisher","first-page":"c7401","DOI":"10.1136\/bmj.c7401","volume":"342","author":"RW Chiu","year":"2011","unstructured":"Chiu RW, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, Lun FM, Go AT, Lau ET, To WW, Leung WC, Tang RY, Au-Yeung SK, Lam H, Kung YY, Zhang X, Van Vugt JM, Minekawa R, Tang MH, Wang J, Oudejans CB, Lau TK, Nicolaides KH, Lo YM. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ. 2011;342:c7401.","journal-title":"BMJ."},{"issue":"6","key":"3570_CR24","first-page":"578","volume":"371","author":"DW Bianchi","year":"2014","unstructured":"Bianchi DW, Rava RP, Sehnert AJ. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med. 2014;371(6):578.","journal-title":"N Engl J Med"},{"issue":"5","key":"3570_CR25","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/uog.14792","volume":"45","author":"H Zhang","year":"2015","unstructured":"Zhang H, Gao Y, Jiang F, Fu M, Yuan Y, Guo Y, Zhu Z, Lin M, Liu Q, Tian Z, Zhang H, Chen F, Lau TK, Zhao L, Yi X, Yin Y, Wang W. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Ultrasound Obstet Gynecol. 2015;45(5):530\u20138.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9","key":"3570_CR26","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/s41436-019-0467-4","volume":"21","author":"D Liang","year":"2019","unstructured":"Liang D, Cram DS. Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes. Genetics In Medicine. 2019;21(9):1998\u20132006.","journal-title":"Genetics In Medicine."},{"key":"3570_CR27","volume-title":"Current use of noninvasive prenatal testing in Europe, Australia and the USA: a graphical presentation","author":"K Gadsboll","year":"2020","unstructured":"Gadsboll K, Petersen OB, Gatinois V. Current use of noninvasive prenatal testing in Europe, Australia and the USA: a graphical presentation; 2020."},{"issue":"19","key":"3570_CR28","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1056\/NEJMp048087","volume":"351","author":"LJ Heffner","year":"2004","unstructured":"Heffner LJ. Advanced maternal age--how old is too old? N Engl J Med. 2004;351(19):1927\u20139.","journal-title":"N Engl J Med"},{"issue":"10","key":"3570_CR29","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/s10038-018-0453-8","volume":"63","author":"T Yamada","year":"2018","unstructured":"Yamada T, Sekizawa A, Fujii Y, Hirose T, Samura O, Suzumori N, Miura K. Maternal age-specific risk for trisomy 21 based on the clinical performance of NIPT and empirically derived NIPT age-specific positive and negative predictive values in Japan. J Hum Genet. 2018;63(10):1035\u201340.","journal-title":"J Hum Genet."},{"issue":"2","key":"3570_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/ajmg.c.31505","volume":"172","author":"A Mardy","year":"2016","unstructured":"Mardy A, Wapner RJ. Confined placental mosaicism and its impact on confirmation of NIPT results. Am J Med Genet C Semin Med Genet. 2016;172(2):118\u201322.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"3","key":"3570_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/uog.14791","volume":"45","author":"MM Gil","year":"2015","unstructured":"Gil MM, Quezada MS, Revello R, Akolekar R, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2015;45(3):249\u201366.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"8","key":"3570_CR32","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/gim.2014.3","volume":"16","author":"FR Grati","year":"2014","unstructured":"Grati FR, Malvestiti F, Ferreira JC, Bajaj K, Gaetani E, Agrati C, Grimi B, Dulcetti F, Ruggeri AM, De Toffol S, Maggi F, Wapner R, Gross S, Simoni G. Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med. 2014;16(8):620\u20134.","journal-title":"Genet Med"},{"issue":"9","key":"3570_CR33","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/gim.2013.26","volume":"15","author":"AL Hall","year":"2013","unstructured":"Hall AL, Drendel HM, Verbrugge JL, Reese AM, Schumacher KL, Griffith CB, Weaver DD, Abernathy MP, Litton CG, Vance GH. Positive cell-free fetal DNA testing for trisomy 13 reveals confined placental mosaicism. Genet Med. 2013;15(9):729\u201332.","journal-title":"Genet Med."},{"issue":"3","key":"3570_CR34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/uog.13277","volume":"43","author":"TK Lau","year":"2014","unstructured":"Lau TK, Cheung SW, Lo PS, Pursley AN, Chan MK, Jiang F, Zhang H, Wang W, Jong LF, Yuen OK, Chan HY, Chan WS, Choy KW. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center. Ultrasound Obstet Gynecol. 2014;43(3):254\u201364.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"3570_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/pd.4123","volume":"33","author":"T Futch","year":"2013","unstructured":"Futch T, Spinosa J, Bhatt S, De Feo E, Rava RP, Sehnert AJ. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn. 2013;33(6):569\u201374.","journal-title":"Prenat Diagn"},{"issue":"7","key":"3570_CR36","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/pd.4126","volume":"33","author":"JA Canick","year":"2013","unstructured":"Canick JA, Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenat Diagn. 2013;33(7):667\u201374.","journal-title":"Prenat Diagn"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03570-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-021-03570-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03570-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T07:20:25Z","timestamp":1611645625000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-03570-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,26]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3570"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-03570-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-52792\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-61696\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-61696\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-61696\/v3","asserted-by":"object"}]},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,26]]},"assertion":[{"value":"14 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Jiaxing Maternal and Child Health Hospital. All participants gave their informed consent in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}